SciSparc Ltd. Ordinary Shares
SPRCSciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) disorders. The company specializes in leveraging proprietary formulations of cannabinoids and other compounds to address conditions such as schizophrenia, autism spectrum disorder, and other neurological and psychiatric conditions. SciSparc aims to advance innovative therapies through research and clinical trials to improve patient outcomes in CNS health.
Company News
SciSparc's subsidiary NeuroThera Labs has signed a non-binding term sheet to acquire a 55% stake in an Israeli quantum computing bio data analysis company, aiming to leverage quantum computing principles for more efficient clinical data processing and research.
Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.
Use these tips to handle short term penny stocks price movements The post Dealing With Penny Stocks’ Short Term Price Movements appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
